tolvaptan has been researched along with Kidney Stones in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoorn, EJ; Zietse, R | 1 |
| Gaur, P; Gedroyc, W; Hill, P | 1 |
| Cheungpasitporn, W; Enders, F; Erickson, SB; Lieske, JC; Rule, AD | 1 |
| de Boer, H; Janssens, PM; Roelofsen, A | 1 |
1 review(s) available for tolvaptan and Kidney Stones
| Article | Year |
|---|---|
ADPKD-what the radiologist should know.
Topics: Antidiuretic Hormone Receptor Antagonists; Carcinoma, Renal Cell; Cysts; Diagnosis, Differential; Diagnostic Imaging; Disease Progression; Humans; Kidney Calculi; Kidney Neoplasms; Polycystic Kidney, Autosomal Dominant; Tolvaptan | 2019 |
1 trial(s) available for tolvaptan and Kidney Stones
| Article | Year |
|---|---|
Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.
Topics: Adolescent; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Calcium Oxalate; Calcium Phosphates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drinking; Female; Follow-Up Studies; Humans; Hyponatremia; Kidney Calculi; Male; Middle Aged; Retrospective Studies; Time Factors; Tolvaptan; Treatment Outcome; Uric Acid; Young Adult | 2016 |
2 other study(ies) available for tolvaptan and Kidney Stones
| Article | Year |
|---|---|
ADPKD, Tolvaptan, and Nephrolithiasis Risk.
Topics: Antidiuretic Hormone Receptor Antagonists; Humans; Kidney Calculi; Polycystic Kidney, Autosomal Dominant; Tolvaptan | 2020 |
Antidiuretic hormone antagonist to reduce cystine stone formation.
Topics: Adult; Benzazepines; Cystinuria; Female; Humans; Kidney Calculi; Male; Middle Aged; Secondary Prevention; Tolvaptan; Vasopressins | 2012 |